Panorama: From Italy the cure for T1D: Dall’Italia la cura contro il diabete di tipo uno – Panorama
Date: 2 February 2021
A drug, created and studied in Italy, could free diabetics from the famous insulin shot.
StartUs Insights: 5 Top Gastrointestinal Drug Startups Impacting The Pharma Sector
Date: 18 December 2020
StatUs Insights analyzed 153 gastrointestinal drug startups impacting the pharma sector. OrphoMed, Enthera, Edesa Biotech, Scioto Biosciences & BiomX clinical assets were identified as 5 top solutions to watch out for.
Business Insider: 21 biotech startups that are set to take off, according to top VCs
Date: 13 August 2020
Link: Business Insider
Enthera named as a start-up poised to take off in the next year by a top biotech venture capitalist due to its work on developing innovative therapeutics for Type 1 diabetes and inflammatory bowel disease.